Market Pulse
High Court rules against Drax and Infinis over green tax change
The UK High Court has ruled against London-listed power generation company Drax and renewable energy firm Infinis Energy, after they urged a review of the government’s decision to remove the climate change levy exemption.
FTSE 250 movers: Domino's leads index after upgrade
The FTSE 250 made some ground on Wednesday, with the second tier index up 252. 74 points (1. 65%) to 15,569. 67 by mid-afternoon.
Tighter financial conditions could weigh on economic outlook, Fed's Yellen says
Financial conditions in the US had become "less supportive" of economic growth and could weigh on the outlook should they persist, the chair of the US Federal Reserve, Janet Yellen, would tell Congressmen on Wednesday, according to the prepared remarks for her testimony.
4D Pharma expands research with Tuscana acquisition
4D Pharma expanded its research capabilities on Wednesday, acquiring university-based startup Tuscana Health Limited.
FTSE 100 movers: Housebuilders lead market higher
The FTSE 100 was set to turn things around on Wednesday, with the blue chip market up 48. 39 points (0. 86%) to 5,680. 58 by mid-afternoon.
Tullow Oil pegs back full year loss to $1bn
Tullow Oil has nearly halved its full year loss, however the company’s revenues for the year have dropped substantially.
Pinnacle Technology completes placing and open offer
Shareholders in Pinnacle Technology were proving their loyalty to the firm on Wednesday, with the company revealing its previously-announced open offer had been significantly oversubscribed.
EU and US reach agreement on derivatives
The European Union and the US have reached an agreement over derivatives that will see them adopt a “common approach” to clearing houses’ requirements, ending a long-standing dispute.
Tesco buys out Harris & Hoole coffee chain
Supermarket retailer Tesco has bought the remaining stake in coffee chain Harris & Hoole it did not already own.
Artilium strengthens call centre offer with Livecom acquisition
Artilium was strengthening its call centre offer on Wednesday, announcing the acquisition of both Livecom International BV and the Chinese joint venture of Livecom.
Eden Research bounces on first commercial order for Mevalone
Eden Research has received its first order for its Mevalone grape crop treatment from partner K&N Efthymiadis that will generate first revenue from the agreement.
Asahi offers to get SABmiller's beers in
Japan's Asahi has offered to pay €2. 55bn to acquire SABMiller's Peroni, Grolsch, and Meantime beer brands from Anheuser-Busch InBev to help the merger swerve competition concerns.
Pinewood still growing as it mulls possible sale
Pinewood Studios was holding steady on its growth trajectory in the second half of the year, as the company revealed it was undergoing a strategic review that could lead to its sale.
Real Good Food buys Devon-based Chantilly Patisserie
Real Good Food’s wholly-owned subsidiary Haydens Bakery has bought Chantilly Patisserie for £1. 75m, using existing cash resources.
US pre-open: Investors standing by for Yellen's testimony
US futures had risen in anticipation of Janet Yellen’s testimony to the House Financial Services Committee on Wednesday.
GW Pharma losses increase ahead of key epilepsy trial results
Cannabis-derived medicines specialist GW Pharmaceuticals posted a £17. 7m loss in the first quarter as it gears up to report data from four Phase 3 trials for its Epidiolex product.
Wednesday newspaper share tips: Avoid Sophos and Tui AG
Sophos Group was under the microscope in The Telegraph’s Questor on Wednesday.
Sales grow at Animalcare, but investment eats into profit
Animalcare was looking at an increase in sales in its first half results on Wednesday, though profits were down in the six months to 31 December 2015 as the company pressed ahead with its investment strategy.
RBC upgrades Shire to 'outperform' ahead of results
RBC Capital Markets upgraded Shire to ‘outperform’ from ‘sector perform’, keeping the $240 price target ahead of the company’s fourth quarter results on Thursday.
Shire's deputy chairman David Kappler to step down
Specialty biopharmaceutical company Shire said David Kappler will step down as deputy chairman and senior independent director.